Issue: April 2017, Posted Date: 4/10/2017

Aptar Pharma Unveils its eDose Counter for MDIs at RDD Europe 2017


Aptar Pharma recently announced it will present its patented eDose Counter for Metered Dose Inhalers (MDIs), designed to be easy-to-use and reliable, and contributes to patient compliance, at the RDD Europe 2017 conference in Nice France, April 25-28, 2017.


Our unique sensing technology offers direct detection of the spray which eliminates risks of miscounting. The sensing technology is versatile and compatible with any metering valve design. Our eDose Counter for MDIs includes inhaler priming and medication reminders-to-use and end-of-product-life warnings (flashing digits) while remaining cost-effective.


For more information on Aptar Pharma’s eDose Counter for MDIs, please meet us at our table top at RDD Europe 2017 conference and/or visit our website:



About Aptar Pharma

Aptar Pharma is part of the AptarGroup, Inc. family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. The company creates innovative drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world.


Aptar Pharma provides customers with a wide range of delivery technologies and analytical services backed by decades of proven expertise. AptarGroup is headquartered in Crystal Lake, Illinois, United States, with manufacturing facilities in North America, Europe, Asia and South America. For more information, visit



+ 33 1 39 17 20 20

Related Taxonomy
This record has been viewed 488 times.

Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions